AAN

Amantadine promotes rapid functional recovery in patients with disorders of consciousness after traumatic brain injury.

Study shows that rivastigmine provides an equal or larger number of quality-adjusted life-years at a lower cost than other treatments.

Patients treated with Levadex, an orally inhaled dihydroergotamine, experienced significant migraine pain relief, even when treated hours after symptom onset.

Study results presented at AAN 2011 show that an experimental oral drug reduces the loss in ambulatory function in boys with Duchenne muscular dystrophy.

Mayo Clinic researchers can predict whether patients will suffer a faster onset of disability and counsel them to help ease anxiety.

Film and television actress Lea Thompson is the host of the American Academy of Neurology Foundation's latest patient education video and guidebook.

The drug laquinimod reduced the number of relapses for people with multiple sclerosis (MS), in a large, long-term Phase III clinical study.

The American Academy of Neurology has issued a new guideline on the most effective treatments for diabetic nerve pain.

When a dementia diagnosis isn't Alzheimer's diease, the neurologist's job becomes much trickier.

When a neurologist encounters a patient with a form of NBIA, it's often their first patient with NBIA.

Dr. Bruce Miller previews what he will be discussing about frontotemporal dementia at the upcoming American Academy of Neurology Annual Meeting.

Dr. Jeffrey Burns previews what he will be discussing about Alzheimer's disease at the upcoming American Academy of Neurology Annual Meeting.

Scheduling, session topics, keynote speakers, and other information for physicians planning to attend AAN 2011.

"Sudden death is 24 times more likely in someone with epilepsy than in the normal population," Elizabeth J. Donner, MD, assistant professor of neurology, University of Toronto said in her plenary lecture "Sudden Unexplained Death in Epilepsy."

In a striking case report, the stimulant modafinil was able to dramatically improve neurological functioning in an elderly woman suffering from bilateral thalamic infarction, a disorder that often is fatal.

Getting people who are having an acute stroke to the hospital in time for thrombolytic therapy appears to be thwarted by a variety of barriers, including the desire of a the patient to avoid being embarrassed an ambulance showing up at the front door.

Interviews with poster presenters at the American Academy of Neurology’s 61st Annual Meeting

Dr. Busis talks about the current health IT climate, AAN efforts to educate members about the use of health IT in practice, the recently passed HITECH Act, the importance of interoperability, future drivers of health IT adoption, and more.

The history of the neurologic examination, referral pattern among neurologists for neurointerventional procedures, Parkinson's disease on the Internet, and online learning are just a few of the many topics discussed during the Day 2 sessions at the AAN meeting.

In a wide-ranging review of the evidence base for the current standard of care for primary brain tumors and other central nervous system malignancies, Amy A. Pruitt, MD, touched on a variety of topics in neuro-oncology, including an overview of the epidemiology and diagnosis of primary brain tumors.

Here are 10 studies about Parkinson's disease which were among the hundreds cited by Susan H. Fox, MD, PhD, during her presentation on movement disorders at the 61st Annual Meeting of the American Academy of Neurology.

The "Guidelines, Practice, and Advocacy Open House Featuring Digital Demos" session had two things going for it that made it an easy choice for us to attend the and cover it for MDNG readers: 1) the tagline "Technology Solutions that You Can Afford" and 2) the triple bill of David Kibbe, MD; former MDNG: Neurology Edition Physician Editor-in-Chief Daniel Hier, MD, MBA, FAAN; and current MDNG: Neurology Edition Health IT Advisory Board member and columnist Steven Zuckerman, MD. The good doctors (and their colleagues) did not disappoint.